Gainers
Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint.
As one Republican governor after another rejects President Biden’s suggestion to pardon simple cannabis possession convictions, one wonders what they're thinking.
Companies Reporting Before The Bell
• Commerce Bancshares (NASDAQ:CBSH) is projected to report quarterly earnings at $1.03 per share on revenue of $383.31 million.